company background image
4197 logo

Visgeneer TPEX:4197 Stock Report

Last Price

NT$9.77

Market Cap

NT$294.9m

7D

0%

1Y

-8.7%

Updated

25 Dec, 2024

Data

Company Financials

4197 Stock Overview

Provides health solutions in the fields of medical device, cosmetics and skin care, bacterial fermentation, and cancer gene diagnostics in Europe and Asia. More details

4197 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Visgeneer Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Visgeneer
Historical stock prices
Current Share PriceNT$9.77
52 Week HighNT$12.55
52 Week LowNT$8.80
Beta0.25
1 Month Change3.17%
3 Month Change3.94%
1 Year Change-8.69%
3 Year Change-23.07%
5 Year Change-27.36%
Change since IPO-67.80%

Recent News & Updates

Recent updates

Does Visgeneer (GTSM:4197) Have A Healthy Balance Sheet?

Apr 15
Does Visgeneer (GTSM:4197) Have A Healthy Balance Sheet?

Shareholder Returns

4197TW Medical EquipmentTW Market
7D0%2.1%0.5%
1Y-8.7%-4.7%27.8%

Return vs Industry: 4197 underperformed the TW Medical Equipment industry which returned -4.7% over the past year.

Return vs Market: 4197 underperformed the TW Market which returned 27.8% over the past year.

Price Volatility

Is 4197's price volatile compared to industry and market?
4197 volatility
4197 Average Weekly Movement5.6%
Medical Equipment Industry Average Movement3.8%
Market Average Movement4.4%
10% most volatile stocks in TW Market7.8%
10% least volatile stocks in TW Market2.1%

Stable Share Price: 4197 has not had significant price volatility in the past 3 months compared to the TW market.

Volatility Over Time: 4197's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2005n/aKengshuo Daiwww.visgeneer.com.tw

Visgeneer Inc. provides health solutions in the fields of medical device, cosmetics and skin care, bacterial fermentation, and cancer gene diagnostics in Europe and Asia. The company offers blood glucose and ketone, uric acid, and cholesterol monitoring systems. It also provides functional masks, such as wood pulp mask, invisible mask, black mask, pure cloth mask, and bio cellulose mask; face cream, night cream, day cream, wrinkle cream, repairing cream, whitening cream, exfoliating cream, toner, and lotions; functional essences; body lotion and spa clay mask; physical blocker, chemical blocker, and comprehensive sun protection; face wash, wash cream, cleaning cleansing mousse, cleaning cleansing gel, shampoo, and body wash; hand cream, knee cream, foot mask, hand mask, and glucosamine cream; anti-acne cream, female private cleaning lotion, skin care, skin capsules, and hair capsules; and customized skin care products.

Visgeneer Inc. Fundamentals Summary

How do Visgeneer's earnings and revenue compare to its market cap?
4197 fundamental statistics
Market capNT$294.87m
Earnings (TTM)-NT$31.00m
Revenue (TTM)NT$119.27m

2.5x

P/S Ratio

-9.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4197 income statement (TTM)
RevenueNT$119.27m
Cost of RevenueNT$61.27m
Gross ProfitNT$58.00m
Other ExpensesNT$89.00m
Earnings-NT$31.00m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.03
Gross Margin48.63%
Net Profit Margin-26.00%
Debt/Equity Ratio77.9%

How did 4197 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 21:01
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Visgeneer Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution